Search

Author/Creator Lacabaratz, Christine

1. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Issue 6 (21st December 2006)

Authors:
Sellam, Jérémie; Miceli-Richard, Corinne; Gottenberg, Jacques-Eric; Ittah, Marc; Lavie, Frédéric; Lacabaratz, Christine; Gestermann, Nicolas; Proust, Alexis; Lambotte, Olivier; Mariette, Xavier
Journal:
Annals of the rheumatic diseases
Issue:
Volume 66:Issue 6(2007)
Page Start:
790
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Dendritic cell‐based therapeutic vaccine elicits polyfunctional HIV‐specific T‐cell immunity associated with control of viral load. Issue 9 (September 2014)

Authors:
Lévy, Yves; Thiébaut, Rodolphe; Montes, Monica; Lacabaratz, Christine; Sloan, Louis; King, Bryan; Pérusat, Sophie; Harrod, Carson; Cobb, Amanda; Roberts, Lee K.; Surenaud, Mathieu; Boucherie, Céline; Zurawski, Sandra; Delaugerre, Constance; Richert, Laura; Chêne, Geneviève; Banchereau, Jacques; P...
Journal:
European journal of immunology
Issue:
Volume 44:Issue 9(2014:Sep.)
Page Start:
2802
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prevention of Ebola virus disease through vaccination: where we are in 2018. Issue 10149 (1st September 2018)

Authors:
Lévy, Yves; Lane, Clifford; Piot, Peter; Beavogui, Abdul Habib; Kieh, Mark; Leigh, Bailah; Doumbia, Seydou; D'Ortenzio, Eric; Lévy-Marchal, Claire; Pierson, Jerome; Watson-Jones, Deborah; Nguyen, Vinh-Kim; Larson, Heidi; Lysander, Julia; Lacabaratz, Christine; Thiebaut, Rodolphe; Augier, Augustin...
Journal:
Lancet
Issue:
Volume 392:Issue 10149(2018)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2021)

Authors:
Pollard, Andrew J; Launay, Odile; Lelievre, Jean-Daniel; Lacabaratz, Christine; Grande, Sophie; Goldstein, Neil; Robinson, Cynthia; Gaddah, Auguste; Bockstal, Viki; Wiedemann, Aurelie; Leyssen, Maarten; Luhn, Kerstin; Richert, Laura; Bétard, Christine; Gibani, Malick M; Clutterbuck, Elizabeth A; ...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 4(2021)
Page Start:
493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. (13th November 2017)

Authors:
Thiébaut, Rodolphe; Hue, Sophie; Le Marec, Fabien; Lelièvre, Jean-Daniel; Dupon, Michel; Foucat, Emile; Lazaro, Estibaliz; Dabis, François; Duffau, Pierre; Wittkop, Linda; Surenaud, Mathieu; Pellegrin, Isabelle; Lacabaratz, Christine; Bonnet, Fabrice; Lévy, Yves
Journal:
AIDS
Issue:
Volume 31:Number 17(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗